Clene Inc.

CLNN

Clene Inc.

CLNN

Insider Sentiment (TTM):

Last Purchase:2026-01-13Last Sale:2026-05-12Shares Purchased (TTM):33,333Shares Sold (TTM):395,002

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:2,193,637Shares Outstanding:11,644,214Institutional Ownership Pct.:18.84%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Cash And Cash Equivalents At Carrying Value	10	6	5	8	7	10	12	15	22	22	29	42
Accounts Receivable Net Current	-	-	0	0	0	0	0	0	0	0	0	0
Assets Current
Assets Current	15	13	9	13	12	15	16	20	28	32	39	46
Marketable Securities Current	-	-	-	-	-	-	0	0	0	6	6	0
Inventory Net	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	5	7	4	5	5	5	4	5	6	4	4	4
Restricted Cash Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	3	3	3	3	3	4	4	4	4	4	4	4
Property Plant And Equipment And Finance Lease Rig…	-	6	6	6	7	7	7	8	8	9	9	10
Assets	23	22	18	22	22	25	27	32	40	45	52	60
Accounts Payable Current	1	1	1	1	1	1	1	2	1	2	2	2
Accrued Liabilities Current	2	3	5	5	5	5	8	7	6	4	4	3
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Liabilities Current
Liabilities Current	5	7	11	8	8	11	10	24	28	26	25	15
Notes Payable Current	-	-	-	-	-	3	0	11	20	15	15	10
Mediumterm Notes Current	0	1	2	1	0	-	0	-	-	-	-	-
Finance Lease Liability Current	-	-	-	-	-	-	0	0	0	0	0	0
Convertible Notes Payable Current	0	1	2	1	-	-	0	-	-	-	-	-
Operating Lease Liability Noncurrent	3	3	3	3	4	4	4	4	5	5	5	5
Finance Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Convertible Debt Current	-	-	-	-	-	-	0	0	0	5	5	-
Long Term Notes Payable	5	5	4	5	5	2	5	2	2	2	2	7
Liabilities	48	40	36	35	31	30	36	36	41	41	39	39
Convertible Debt Noncurrent	-	-	-	-	-	-	11	-	-	-	5	-
Derivative Liabilities Noncurrent	-	-	-	-	-	-	-	1	1	3	1	2
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Stockholders Equity	-25	-19	-18	-12	-9	-5	-9	-4	-1	4	13	21
Additional Paid In Capital	305	297	291	287	282	278	273	264	260	258	256	254
Retained Earnings Accumulated Deficit	-330	-316	-308	-299	-290	-283	-282	-269	-261	-254	-243	-233
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities And Stockholders Equity	23	22	18	22	22	25	27	32	40	45	52	60
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	600	600	600	600	600	600	600	600	600	300	300	300
Common Stock Shares Issued	13	12	11	10	9	9	8	7	6	6	6	6
Shares Outstanding	13	12	11	10	9	9	8	7	6	6	6	6

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-22.70%	-13.48%	-28.51%	-	-	-	-	-	-	-	-	-
2025	25.10%	47.45%	43.14%	67.50%	191.94%	247.22%	-20.96%	-20.96%	-43.97%	-0.33%	18.76%	-11.09%
2024	-15.38%	-7.69%	-42.44%	17.11%	7.11%	18.89%	-8.71%	10.79%	-6.85%	-23.47%	-34.44%	4.59%
2023	-	-	-	-	-	-	2.38%	-28.57%	26.19%	-6.82%	-2.27%	-25.00%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.07	1.94	0.83	1.53	1.58	1.36	1.57	0.83	0.99	1.23	1.53	3.04
Quick Ratio	2.00	0.88	0.48	0.95	0.96	0.91	1.19	0.61	0.77	1.07	1.39	2.76
Working Capital	10.06M	6.29M	-1.80M	4.37M	4.41M	3.91M	5.87M	-4.13M	-159.00K	5.93M	13.52M	31.18M
Leverage & Debt
Debt to Equity	-1.93	-2.15	-2.03	-2.81	-3.59	-6.09	-4.09	-8.65	-81.02	9.57	2.91	1.82
Interest Coverage TTM	-7.13	-7.35	-8.61	-9.89	-9.35	-8.15	-8.14	-7.24	-7.35	-8.24	-8.89	-9.92
Debt Ratio	2.08	1.87	1.97	1.55	1.39	1.20	1.32	1.13	1.01	0.91	0.74	0.65
Efficiency & Turnover
Asset Turnover TTM	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Days Sales Outstanding TTM	-	-	-	-	-	-	110.46	-	-	37.38	92.65	48.29
Receivables Turnover TTM	-	-	-	-	-	-	3.30	-	-	9.76	3.94	7.56
Per Share Metrics
Free Cash Flow Per Share TTM	-1.33	-1.55	-1.89	-1.32	-1.33	-2.18	-3.07	-3.61	-4.28	-4.39	-5.83	-5.11
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	78.86%	79.53%	78.62%	81.00%	78.71%	81.50%	87.47%
Operating Profit Margin TTM	-10,431.98%	-15,722.39%	-11,541.50%	-11,328.50%	-9,234.27%	-7,982.00%	-9,676.32%	-8,163.42%	-8,166.29%	-6,296.77%	-6,198.78%	-5,889.00%
Net Profit Margin TTM	-20,059.90%	-25,009.70%	-13,086.50%	-14,250.47%	-10,386.36%	-8,306.00%	-11,520.47%	-8,556.77%	-6,890.50%	-7,873.23%	-7,569.42%	-5,624.65%
Growth Metrics
Net Revenue Growth (1Y)	-31.12%	-61.71%	-41.52%	-49.17%	-35.29%	-43.55%	-47.71%	-41.36%	-43.62%	12.73%	38.27%	63.93%
Net Income Growth (1Y)	33.03%	15.28%	-33.57%	-15.35%	-2.47%	-40.45%	-20.41%	-10.80%	-37.77%	72.28%	65.47%	65.23%
EPS Growth (1Y)	2.32%	-12.63%	-53.14%	-46.02%	-34.22%	-56.66%	-39.95%	-12.67%	-58.32%	2.02%	2.81%	-18.28%
Valuation Metrics
P/E TTM	-1.93	-1.71	-2.21	-2.03	-1.25	-0.93	-0.94	-0.84	-1.52	-1.13	-0.64	-1.59
P/B TTM	-3.08	-3.05	-3.29	-5.02	-4.36	-5.47	-4.17	-7.30	-91.76	12.95	2.35	3.00
P/S TTM	387.20	428.40	289.36	289.80	130.20	77.66	107.97	71.50	104.63	89.07	48.14	89.42
Market Cap	76.28M	57.41M	57.87M	62.02M	37.24M	27.18M	36.93M	30.10M	46.25M	55.22M	31.48M	64.20M
Enterprise Value	71.92M	56.92M	58.74M	59.17M	34.51M	22.35M	40.50M	27.94M	46.70M	55.29M	29.28M	38.34M
Calculated Values
Free Cash Flow TTM	-16.43M	-18.10M	-18.59M	-13.61M	-12.63M	-19.26M	-21.34M	-23.69M	-27.47M	-28.18M	-30.58M	-32.78M
Net Debt	-4.36M	-488.00K	872.00K	-2.85M	-2.72M	-4.83M	3.57M	-2.16M	458.00K	66.00K	-2.20M	-25.86M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-12Sale

Owner: Ugwumba, Chidozie

Title: -

Shares: 73,296

Price/Share: $6.20

Value: $454,435.20

Shares Owned: 103,417

Relationship: TenPercentOwner

Ownership: Indirect

2026-05-04Sale

Owner: Ugwumba, Chidozie

Title: -

Shares: 72,884

Price/Share: $6.80

Value: $495,611.20

Shares Owned: 198,890

Relationship: TenPercentOwner

Ownership: Indirect

2026-04-30Sale

Owner: Ugwumba, Chidozie

Title: -

Shares: 5,736

Price/Share: $6.08

Value: $34,874.88

Shares Owned: 277,569

Relationship: TenPercentOwner

Ownership: Indirect

2026-04-21Sale

Owner: Ugwumba, Chidozie

Title: -

Shares: 61,345

Price/Share: $6.14

Value: $376,658.30

Shares Owned: 297,066

Relationship: TenPercentOwner

Ownership: Indirect

2026-04-17Sale

Owner: Ugwumba, Chidozie

Title: -

Shares: 25,040

Price/Share: $6.43

Value: $161,007.20

Shares Owned: 362,729

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-12	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	73,296	6.20	$454,435.20	103,417	4
2026-05-04	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	72,884	6.80	$495,611.20	198,890	4
2026-04-30	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	5,736	6.08	$34,874.88	277,569	4
2026-04-21	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	61,345	6.14	$376,658.30	297,066	4
2026-04-17	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	25,040	6.43	$161,007.20	362,729	4
2026-04-02	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	24,925	4.81	$119,889.25	401,891	4
2026-04-01	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	4,278	4.97	$21,261.66	426,816	4
2026-03-30	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	15,536	5.10	$79,233.60	499,085	4
2026-03-26	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	5,319	5.40	$28,722.60	532,091	4
2026-02-03	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	5,559	4.10	$22,791.90	550,000	4
2026-02-02	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	3,800	4.04	$15,352.00	555,559	4
2026-01-28	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	8,717	4.91	$42,800.47	580,329	4
2026-01-23	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	5,556	5.27	$29,280.12	599,603	4
2026-01-21	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	12,119	5.05	$61,200.95	617,824	4
2026-01-15	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	12,563	5.10	$64,071.30	650,298	4
2026-01-13	Matlin, David J	Director	-	Direct	Purchase	33,333	6.50	$216,664.50	477,824	4
2026-01-12	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	32,705	5.50	$179,877.50	708,587	4
2026-01-07	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	3,938	6.29	$24,770.02	753,562	4
2026-01-02	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	4,015	5.73	$23,005.95	766,480	4
2025-12-30	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	4,138	6.03	$24,952.14	783,590	4
2025-12-26	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	3,350	6.32	$21,172.00	795,824	4
2025-12-22	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	4,367	6.54	$28,560.18	383,201	4
2025-12-18	Ugwumba, Chidozie	TenPercentOwner	-	Indirect	Sale	5,816	6.33	$36,815.28	393,150	4
2025-08-21	General, Resonance Llc	TenPercentOwner	-	Direct	Sale	3,401	5.34	$18,161.34	704,591	4
2025-06-04	General, Resonance Llc	TenPercentOwner	-	Direct	Sale	600	4.04	$2,424.00	707,992	4
2025-06-02	General, Resonance Llc	TenPercentOwner	-	Direct	Sale	600	4.12	$2,472.00	708,592	4
2025-05-30	General, Resonance Llc	TenPercentOwner	-	Direct	Sale	410	2.80	$1,148.00	709,192	4
2025-05-29	General, Resonance Llc	TenPercentOwner	-	Direct	Sale	410	2.73	$1,119.30	709,602	4
2025-05-28	General, Resonance Llc	TenPercentOwner	-	Direct	Sale	420	2.60	$1,092.00	710,012	4
2025-05-27	General, Resonance Llc	TenPercentOwner	-	Direct	Sale	420	2.45	$1,029.00	710,432	4
2025-03-19	General, Resonance Llc	TenPercentOwner	-	Direct	Sale	1,400	4.40	$6,160.00	710,852	4
2024-09-30	Matlin, David J	Director	-	Direct	Purchase	92,307	4.75	$438,458.25	444,491	4
2024-09-30	Etherington, Robert Dee	Director,Officer	Chief Executive Officer	Direct	Purchase	10,000	4.75	$47,500.00	40,149	4
2024-09-30	Mortenson, Mark	Officer	Chief Science Officer	Direct	Purchase	20,512	4.75	$97,432.00	28,949	4
2024-05-01	General, Resonance Llc	TenPercentOwner	-	Direct	Sale	13,000	0.40	$5,200.00	15,313,712	4
2024-04-24	General, Resonance Llc	TenPercentOwner	-	Direct	Sale	10,000	0.33	$3,300.00	15,349,712	4
2024-04-09	General, Resonance Llc	TenPercentOwner	-	Direct	Sale	22,500	0.39	$8,775.00	15,428,212	4
2023-11-10	Matlin, David J	Director	-	Direct	Purchase	250,002	0.41	$102,500.82	7,043,686	4
2023-06-26	Etherington, Robert Dee	Director,Officer	Chief Executive Officer	Indirect	Purchase	25,000	0.81	$20,250.00	25,000	4
2023-06-26	Stevens, John Henry	Director	-	Direct	Purchase	316,455	0.80	$253,164.00	800,204	4
2023-06-16	Matlin, David J	Director	-	Direct	Purchase	1,500,000	0.80	$1,200,000.00	6,793,684	4
2023-06-16	Gay, Jonathon	Director	-	Indirect	Purchase	105,625	0.80	$84,500.00	105,625	4
2023-06-16	Ugwumba, Chidozie	TenPercentOwner,Other	-	Indirect	Purchase	7,500,000	0.80	$6,000,000.00	13,018,908	4
2023-06-16	Mosca, Alison	Director	-	Indirect	Purchase	2,394,375	0.80	$1,915,500.00	3,238,375	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

18.84%

Inst. Shares: 2,193,637

Shares Outstanding: 11,644,214

2025-12-31

19.65%

Inst. Shares: 1,937,346

Shares Outstanding: 9,858,907

2025-09-30

7.62%

Inst. Shares: 783,757

Shares Outstanding: 10,284,674

2025-06-30

6.10%

Inst. Shares: 580,615

Shares Outstanding: 9,523,592

2025-03-31

5.16%

Inst. Shares: 455,424

Shares Outstanding: 8,824,673

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	2,193,637	11,644,214	18.84%
2025-12-31	1,937,346	9,858,907	19.65%
2025-09-30	783,757	10,284,674	7.62%
2025-06-30	580,615	9,523,592	6.10%
2025-03-31	455,424	8,824,673	5.16%
2024-12-31	490,254	6,954,133	7.05%
2024-09-30	1,002,657	6,557,839	15.29%
2024-06-30	6,748,666	6,423,182	105.07%
2024-03-31	7,234,209	6,421,362	112.66%
2023-12-31	11,563,209	5,246,941	220.38%
2023-09-30	24,249,821	6,420,274	-
2023-06-30	32,066,025	4,302,520	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Clene Inc. (CLNN) — SEC Financial Statements & Analysis

Clene Inc. (CLNN) is a pharmaceutical preparations company, incorporated in DE. Clene Inc. trades on Nasdaq as: CLNN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Clene Inc. reported a -31.12% year-over-year revenue growth, a Gross Profit Margin of 78.86% (TTM), a Debt-to-Equity ratio of -1.93x, a Price-to-Sales (P/S) ratio of 387.20x (TTM), a Price-to-Book (P/B) ratio of -3.08x (TTM), at a market cap of $76.28M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -31.12%
Gross Profit Margin TTM: 78.86%
Debt To Equity: -1.93x
P/S TTM: 387.20x
P/B TTM: -3.08x
Market Cap: $76.28M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Clene Inc. in?

Clene Inc. (CLNN) operates in the Pharmaceutical Preparations industry.

What is CLNN's market cap?

Clene Inc. (CLNN) has a market capitalization of $76.28M as of 2026-06-30.

What exchange does CLNN trade on?

Clene Inc. (CLNN) trades on the Nasdaq.

Where is Clene Inc. incorporated?

Clene Inc. is incorporated in DE.

Clene Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Clene Inc. (CLNN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Clene Inc. (CLNN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.